• Talks
  • Calls
  • Devices
  • Jobs
  • Your Input
  • Contact
  1. MunichCancerTalks
  2. Talks
  3. 2nd DKTK - TranslaTUM Minisymposium

2nd DKTK - TranslaTUM Minisymposium

with Raghu Kalluri, Valerie LeBleu and Hellmut Augustin
TranslaTUM


Agenda 

  • Hellmut Augustin (DKFZ und Univ. of Heidelberg) 
    Vascular Control of Liver Function 
  • Valerie LeBleu (Baylor College of Medicine) 
    Exosomes for personalized medicine in pancreatic cancer: from bench discovery to clinical trial 

  • Raghu Kalluri (MD Anderson Cancer Center) 
    New Insights into Pathobiology and therapy opportunies for Pancreatic Cancer 


Hellmut Augustin, PhD is Professor of Vascular Biology at the Medical Faculty Mannheim of Heidelberg University, Head of the Division for Vascular Oncology and Metastasis Research at the German Cancer Research Center (DKFZ), and Founding Director of the European Center for Angioscience at Heidelberg University, Germany. The Augustin lab (www.augusLnlab.de) studies angiocrine signaling mechanisms and organotypic vascular functional differentiation during the life cycle of a vasculature (blood vessel formation, assembly, maturation, quiescence, regression, aging) with a particular focus on tumor-vessel interactions that govern tumor progression and metastasis. Basic discovery research feeds translational research with the goal of identifying and validating novel therapeutic targets as well as laying the preclinical proof-of-concept for novel treatment modalities and therapeutic windows, including neoadjuvant and adjuvant therapy.

Valerie LeBleu MBA, MD, PhD, is a resident in the Medical Oncology Fast Track Program of Baylor College of Medicine (Houston, TX). She is an editorial board member of Cancer Research and Extracellular Vesicle and serves as a consultant for biotech companies in the areas of Lssue repair and fibrosis. Her research focuses on exosome biology and the remodeling of solid tumor stroma, vascular heterogeneity and metastasis.

Raghu Kalluri, MD, PhD, is the Frederick F. Becker Distinguished University Chair of Cancer Research at MD Anderson Cancer Center. Raghu’s research is focused on the tumor microenvironment, fibroblasts, and extracellular vesicles in cancer progression and metastasis. His pioneering research on exosomes has shown how these vesicles facilitate cancer cell communicaLon, promote metastasis, and serve as potential biomarkers for early cancer detection. He also explores the dual roles of fibroblasts in either  promoting or suppressing cancer growth, especially in pancreatic cancer. Raghu’s work further delves into how exosomes and the tumor stroma affect immune responses to cancer.

TranslaTUM 

Translational Cancer Research and Experimental Cancer Therapy

Einsteinstrasse 25
81675 München
TranslaTUM - Translational Cancer Research and Experimental Cancer Therapy

 keywords: gastro, targeted therapy, immunoonology

Datum

27.09.2024

Uhrzeit

15:00 - 17:30

Ort

TranslaTUM Auditorium Klinikum rechts der Isar Einsteinstrasse 25 81675 München

Veranstalter

Translational Cancer Research and Experimental Cancer Therapy at TranslaTUM

Anmeldung unter


Weitere Informationen

Agenda

iCal-Download

Save the date

Munich Cancer Talks on behalf of

DKTK / Deutsches Konsortium für Translationale Krebsforschung Partnerstandort München

CCC München / Comprehensive Cancer Center München

BZKF / Bayerisches Zentrum für Krebsforschung Standort München

TUM Klinikum / Klinikum Rechts der Isar Technische Universität München

TUM / Technische Universität München

LMU Klinikum

LMU / Ludwig-Maximilians-Universität München

 

Redakteurs Login
Impressum | Datenschutz

Munich Cance...

  • Talks
  • Calls
  • Devices
  • Jobs
  • Your Input
  • Contact